D-0926-2017 Class III Terminated
Recall Details
- Product Type
- Drugs
- Report Date
- July 5, 2017
- Initiation Date
- June 12, 2017
- Termination Date
- February 7, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2980 bottles
Product Description
Gaviscon (Alumina & Magnesium Trisilicate) Regular Strength Original Flavor Chewable Tablets, 80 mg & 14.2 mg, 100-count bottles, Distributed by: GlaxoSmithKline Consumer Healthcare, L.P., Moon Twp, PA 15108, UPC 3 0088-1175-47 8.
Reason for Recall
Superpotent Drug: high out-of-specification result for magnesium.
Distribution Pattern
Nationwide in the USA, Puerto Rico, and the United Kingdom.
Code Information
Lot #: 5J69A, Exp 02/19; 6GF2A, 6GF3A, Exp 08/19